2025年4月17日 星期四
首页        期刊介绍        编委会        投稿指南        期刊订阅        广告合作        联系我们        English
河北医学  2023, Vol. 29 Issue (2): 280-284    DOI: 10.3969/j.issn.1006-6233.2023.02.019
  临床研究 本期目录 | 过刊浏览 | 高级检索 |
sLOX-1 HIF-1α IGF-1对动脉瘤性蛛网膜下腔出血后迟发性脑缺血的预测价值研究
姜海洋1, 陈虎1, 张登文2
1.空军军医大学唐都医院神经外科, 陕西 西安 710038
2.中国人民解放军联勤保障部队第970医院神经外科, 山东 烟台 264000
Predictive Value of sLOX-1, HIF-1α and IGF-1 on Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage
JIANG Haiyang, CHEN Hu, et al
Tangdu Hospital, Air Force Military Medical University, Shanxi Xi'an 710038, China
全文: PDF (1346 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的: 探讨可溶性凝集素样氧化型低密度脂蛋白受体-1(sLOX-1)、缺氧诱导因子-1α(HIF-1α)、胰岛素样生长因子-1(IGF-1)对动脉瘤性蛛网膜下腔出血(aSAH)后迟发性脑缺血(DCI)的预测价值研究。方法: 选取我院2019年3月至2022年3月期间104例aSAH患者作为研究对象,根据DCI发生情况分为DCI组和非DCI组,比较两组一般临床资料[三酰甘油(TG)、颅内压(ICP)、Hunt-Hess分级]及血清sLOX-1、HIF-1α、IGF-1水平,采用Pearson相关性分析血清sLOX-1、HIF-1α、IGF-1与TG、ICP、Hunt-Hess分级的相关性,绘制受试者工作特征(ROC)曲线,评估血清sLOX-1、HIF-1α、IGF-1对aSAH后DCI的预测效能。结果: DCI组TG、ICP、Hunt-Hess分级均高于非DCI组(P<0.05);DCI组血清sLOX-1、HIF-1α水平均高于非DCI组(P<0.05),IGF-1水平低于非DIC组(P<0.05);Pearson相关性分析显示,血清sLOX-1、HIF-1α水平与TG、ICP、Hunt-Hess分级均呈正相关(P<0.05),血清IGF-1水平与TG、ICP、Hunt-Hess分级均呈负相关(P<0.05);ROC曲线显示,血清sLOX-1、HIF-1α、IGF-1单独及联合预测aSAH后DCI的敏感度/特异度分别为87.10%/79.50%、90.30%/83.60%、83.90%/79.50%、96.80%/78.10%,对应的AUC分别为0.894、0.920、0.886、0.975。结论: sLOX-1、HIF-1α、IGF-1与aSAH后DCI的发生有关,联合检测可在一定程度上预测aSAH后DCI。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
姜海洋
陈虎
张登文
关键词 动脉瘤性蛛网膜下腔出血迟发性脑缺血可溶性凝集素样氧化型低密度脂蛋白受体-1缺氧诱导因子-1α胰岛素样生长因子-1预测价值    
AbstractObjective: To explore the predictive value of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1), hypoxia-inducible factor-1α (HIF-1α), and insulin-like growth factor-1 (IGF-1) on delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). Methods: A total of 104 patients with aSAH in the hospital from March 2019 to March 2022 were selected as the research subjects. According to the occurrence of DCI, the patients were divided into a DCI group and a non-DCI group. The general clinical data [triacylglycerol (TG), intracranial pressure (ICP), Hunt-Hess grading] and serum sLOX-1, HIF-1α, and IGF-1 levels were compared between the two groups. Pearson correlation analysis was used to analyze the correlation between serum sLOX-1, HIF-1α, IGF-1 and TG, ICP, and Hunt-Hess grading. The receiver operating characteristic (ROC) curve was drawn to assess the predictive efficiency of serum sLOX-1, HIF-1α, and IGF-1 on DCI after aSAH. Results: The TG, ICP and Hunt-Hess grading in the DCI group were higher than those in the non-DCI group (P<0.05). The levels of serum sLOX-1 and HIF-1α in the DCI group were higher than those in the non-DCI group (P<0.05) while the level of IGF-1 was lower than that in the non-DIC group (P<0.05). Pearson correlation analysis showed that serum sLOX-1 and HIF-1α levels were positively correlated with TG, ICP, and Hunt-Hess grading (P<0.05), but serum IGF-1 level was negatively correlated with TG, ICP, and Hunt-Hess grading (P<0.05). ROC curve showed that the sensitivities and specificities of serum sLOX-1, HIF-1α, IGF-1 alone and in combination on predicting DCI after aSAH were 87.10%/79.50%, 90.30%/83.60%, 83.90%/79.50%, and 96.80%/78.10% respectively, and the corresponding AUCs were 0.894, 0.920, 0.886, and 0.975 respectively. Conclusion: sLOX-1, HIF-1α, and IGF-1 are related to the occurrence of DCI after aSAH, and combined detection can predict DCI after aSAH to a certain extent.
Key wordsAneurysmal subarachnoid hemorrhage    Delayed cerebral ischemia    Soluble lectin-like oxidized low-density lipoprotein receptor-1    Hypoxia-inducible factor-1α    Insulin-like growth factor-1    Predictive value
    
基金资助:国家自然科学基金委员会资助项目,(编号:81671136)
引用本文:   
姜海洋, 陈虎, 张登文. sLOX-1 HIF-1α IGF-1对动脉瘤性蛛网膜下腔出血后迟发性脑缺血的预测价值研究[J]. 河北医学, 2023, 29(2): 280-284.
JIANG Haiyang, CHEN Hu, et al. Predictive Value of sLOX-1, HIF-1α and IGF-1 on Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage. HeBei Med, 2023, 29(2): 280-284.
链接本文:  
http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2023.02.019     或     http://www.hbyxzzs.cn/CN/Y2023/V29/I2/280
冀ICP备2025106803号    冀公网安备13080202000786号
版权所有 © 2016 《河北医学》杂志社
本系统由北京玛格泰克科技发展有限公司设计开发